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Executive Summary 
Diabetes is a serious illness affecting millions of people in the United States today.  The 
disease is characterized by the chronic and acute complications of poorly regulated blood glucose 
concentrations.  These complications lead to significant morbidity and mortality in the diabetic 
population.  It is estimated that diabetes accounts for over $1.9 billion in Kentucky healthcare 
expenditure annually, a figure that continues to grow each year. In order to address this serious 
public health problem, many states have adopted healthcare initiatives to target increased diabetes 
awareness and care.  The Commonwealth of Kentucky has implemented numerous such 
initiatives, including an innovative program of university based academic detailing. 
The Drug and Therapeutics Information Service (DATIS) is a program affiliated with the 
University of Kentucky College of Pharmacy designed to provide area primary care physicians 
with evidence-based guidelines for the treatment of public health concerns.  This program utilizes 
clinical pharmacists to review current primary literature surrounding a topic of interest, prepare 
condensed reference materials based on the salient points of this literature, and participate in one-
on-one academic detailing sessions with area providers.  The program is currently funded by 
federal grants with the potential for transition to state support, prompting the need for audit.  
Management of Type II diabetes was the initial focus of the DATIS group.  The impact 
of the DATIS detailing sessions was assessed using Kentucky Medicaid data.  The frequency of 
hemoglobin A1c assessment in the area of intervention was compared the frequency of 
assessment in a control area.  Statewide hemoglobin A1c assessment was tracked over the same 
timeframe.  No significant difference in assessment frequency was noted between the intervention 
and control areas.  However, an overall statewide increase in assessment frequency was noted 
over the course of the analysis.  These results suggest that further analysis may be necessary to 
determine the impact of the DATIS intervention on diabetes care in the Commonwealth of 
Kentucky.        
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The Effects of a University-Based Academic Detailing Program for Primary Care 
Providers on Hemoglobin A1c Assessment Frequency in Type II Diabetics 
Diabetes is a chronic illness affecting millions of people in the United States 
today.   The disease is characterized by persistently elevated blood glucose levels due to 
deficiencies in production or utilization of the hormone insulin.  Type I diabetes, also 
known as insulin dependent diabetes or juvenile onset diabetes, results from insufficient 
pancreatic secretion of insulin.  Cases of Type I diabetes are most often attributed to 
autoimmune or genetic causes and are largely unpreventable.  Type II diabetes, also 
known as non-insulin dependant diabetes or adult onset diabetes, results from metabolic 
changes that make the body less sensitive to insulin.  Most cases of Type II diabetes 
develop as a result of preventable metabolic changes.  Risk factors for developing Type II 
diabetes include increasing age, obesity, and a sedentary lifestyle. 
 The consequences of uncontrolled diabetes are serious and far-reaching. Diabetic 
patients are predisposed to peripheral nerve damage, kidney damage, and ocular 
complications.  Persistent hyperglycemia predisposes these patients to multiple 
infections, which commonly go unnoticed due to diabetes-associated neuropathies.  
Diabetics are also at much higher risks than the general population for adverse 
cardiovascular events.  The combined effects of uncontrolled diabetes can lead to 
significant morbidity, mortality, and healthcare utilization. 
 In Kentucky over 350,000 individuals have diabetes, with many more cases 
currently undiagnosed [1].  It is estimated that 9.7% of the commonwealth’s adult 
population suffers from the disease.  The combined direct and indirect costs of diabetes in 
Kentucky approached $2.4 billion in 1999[2].  As the prevalence of childhood and 
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adolescent obesity increases, these costs are projected to rise dramatically over the next 
decade.  With the impact on state sponsored healthcare in consideration, it is clear that 
diabetes control has become a crisis of public health and public finance in the 
Commonwealth.    
 Many approaches to increase awareness of recommended management of diabetic 
patients have been suggested.  These include audit and feedback, continuing medical 
education, and academic detailing [3].  Audit and feedback approaches consist of brief 
objective examination followed by a review of practice guidelines.  These approaches are 
most often undertaken by professional organizations such as the American Diabetes 
Association.  Continuing medical education seeks to link competency with requirements 
for continued professional licensure.  Credit toward continuing medical education 
requirements are most often gained through pharmaceutical industry-sponsored seminars 
or presentations.  Each of these two approaches places greater focus on the message than 
the method of conveyance. 
Academic Detailing 
 Academic detailing is an intervention that relies on developing a relationship 
between a physician and an educational visitor, most often a clinically trained pharmacist 
[4,,5,6].  The educational visitor seeks to establish this relationship by providing 
thoroughly researched, non-biased information to the physician as a public health service. 
Optimally, the educational visitor presents this information to the physician in a private 
session arranged at the physicians’ convenience.  Techniques of academic detailing 
emphasize one-on-one interaction, skilled interpersonal communication, and attention to 
the individual needs and interests of each physician [6,7].  The educational visitor also 
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serves as a drug information resource to the physician, reinforcing the role of as a 
provider of unbiased supportive information.  
  Academic detailing has demonstrated considerable efficacy as a method of 
behavior change [3,5,8].  The practice has been proven effective in improving the 
management of acute and chronic health conditions.  To conduct an effective educational 
intervention, the detailer approaches the provider with the following goals: 
• Assess baseline knowledge and motivations for current prescribing patterns 
• Focus on specific disciplines and opinion leaders 
• Define clear educational and behavioral objectives 
• Establish credibility through respected organizational identity 
• Present unbiased information, address each side of controversial issues 
• Stimulate active participation in detailing sessions 
• Highlight and repeat essential messages 
• Provide positive reinforcement during follow-up visits 
The above goals have been established as facets of effective detailing intervention [6]. 
 Drug and Therapeutics Information Service (DATIS) is a continuing medical 
education program offering academic detailing services to physicians in Kentucky.  The 
program was developed as a venture between the University of Kentucky College of 
Pharmacy and the University of Queensland with Repatriation General Hospital in South 
Australia [9].  The DATIS program was developed as a method to further the state public 
health services of the UK College of Pharmacy.  This program utilizes clinical 
pharmacists as educational visitors to provide a health information service to area 
physicians.  
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 The information provided by the educational visitor is targeted to address public 
health needs in the surrounding community.  To this end, topics of discussion include 
prevalent chronic disease states that impose significant health and economic burdens to 
the public.  Discussion topics are also chosen on the basis of potential impact, subjects 
where standards of care and therapeutic alternatives are constantly evolving.  The DATIS 
program initially offered services to primary care physicians in Fayette County covering 
the topics of Type II Diabetes Management and Chronic Nonmalignant Pain. Since the 
program began in 2003, roughly 67% of primary care providers in the Fayette county 
region have participated in academic detailing sessions with DATIS representatives [9]. 
 Once a topic is chosen, the clinical pharmacist conducts a thorough review of 
primary literature published on the subject.  This information is evaluated based on 
regional relevance and the quality of the evidence provided.  The information gathered 
from the literature is then used to create comprehensive reference manuals that are 
provided to physicians during the detailing sessions. These reference manuals, along with 
abbreviated graphic aids that convey a few key messages, are used as focal points for 
discussion.  Periodic revision of these reference manuals is undertaken to assure the 
provided recommendations are accurate and up-to-date.  
Program Funding 
 Initial financial support of the DATIS program was provided through the Centers 
for Disease Control and Prevention in August of 2002.  This funding established the 
Lexington DATIS office, initially extending the service to Fayette County and the 
surrounding area.  An extension of the original CDC funding has allowed the expansion 
of the DATIS services to Western areas of the state with the creation of an office in 
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Hazard, Kentucky.   The program in its entirely is currently supported through the fall of 
2005.   
Recently the Commonwealth of Kentucky provided a letter of agreement offering 
additional funding for the DATIS program.  The funds allocated by the State were to 
allow a continuation of services in Lexington, Hazard, and further expansion of the 
program into regions of Eastern Kentucky.  However, the long-term fate of public 
funding for the DATIS program remains unclear.  The recently allocated state funds were 
withdrawn pending a competitive request for proposals to take place in 2005.  Budget 
concerns and political issues within the state CMS have created obstacles to previously 
secured state funds.  Accordingly, the future of state funding for the DATIS program is 
unclear.   If this funding is indeed extended, the DATIS program will represent a 
substantial expenditure of public funds. 
  As a public program, the funding for the DATIS program comes at the expense of 
potential support for other public services.  The outcomes of such a program must 
demonstrate that the use of public funds is ultimately beneficial to the population at large.  
Furthermore, this benefit must be weighed against alternative uses of the same funds for 
other public services.  Therefore, evaluation of such a program is important from a policy 
standpoint.  In order to receive continued public support, the program must ultimately 
demonstrate a cost-effective improvement in public health outcomes. 
Study Objective 
Many measures to assess diabetes care exist, including fasting blood glucose, 
microalbuminuria, and glycosylated hemoglobin  [2,10].  Glycosylated hemoglobin, or 
A1c, is unique in that it provides the physician with a picture of glucose control over 
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time.  Persistently high blood glucose values lead to a glycosylation of red blood cells, 
which have a lifespan of roughly 90-120 days.  This process is slowly reversible, and 
therefore best reflects glycemic control over the previous two to three months [10,11,12]. 
 National guidelines on management of Type II diabetes indicate A1c as one of the 
primary monitoring parameters for diabetic patients [9,12,13].  Recommendations from 
the American College of Endocrinology suggest A1c should be assessed at baseline for 
all newly diagnosed diabetics.  Follow up assessment should take place every three 
months until glycemic control has stabilized.  Assessment every six months is 
recommended in patients with stable glycemic control. Therefore, the frequency of 
hemoglobin A1c assessment was chosen as a surrogate marker for improved diabetes 
care, and will be measured in patients already identified as diabetics.  This approach has 
been used successfully in previous research of diabetes care quality improvement 
[3,10,14] 
 Consistent monitoring of A1C is one of the key messages stressed by DATIS 
educational visitors during sessions covering Type II diabetes care.  These key messages 
are reinforced multiple times throughout the detailing session, and are highlighted in 
printed material left with the provider.   As such, the frequency of hemoglobin A1c 
assessment also provides a measure of the impact the academic detailing session have 
had on primary care providers.     
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The key hypothesis of this study is: 
 
H0: A program of university-based academic detailing will result in no 
change in the hemoglobin A1c assessment frequency in Type II diabetics 
 
Which will be tested against the alternative: 
 
H1: A program of university-based academic detailing will result in a change 
in the hemoglobin A1c assessment frequency in Type II diabetics 
 
 This research seeks to determine if the academic detailing program can create a 
measurable difference in a common marker of diabetes care.  Previous studies of such 
programs have demonstrated significant differences in the level of care provided pre and 
post intervention [3].  However, certain limitations exist that prevent direct comparison to 
the program in Kentucky.  This study seeks to determine if assessment of A1c monitoring 
frequency can measure the impact of the academic detailing program, and to explore 
possible alternative or additional methods of assessment.      
Methods 
Sampling 
 The population of interest for this study was all Type II diabetics living in the 
Commonwealth of Kentucky.  The population accessible for this study consists of all 
Kentucky Medicaid patients identified as Type II diabetics by the study criteria with 
claims data available within the sampling time frame.  Previous studies demonstrate the 
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utility of retrospective Medicare and Medicaid data in diabetes quality improvement 
initiatives.[5,15]  In order to measure the effect of the intervention which took place over 
12 months, pre- and post- intervention data were gathered.  The pre-intervention period 
examines Medicaid claims processed from March 2002 through February 2003, the post-
intervention period examines Medicaid claims processed from March 2004 through 
February 2005. 
 In order to isolate the effect of the academic detailing service on the population of 
interest, a subpopulation likely to have been effected by the intervention was identified.  
The primary area of intervention was the Lexington/Fayette county region.  Accordingly, 
the intervention subpopulation was comprised of patients residing in Fayette county and 
the immediate surrounding area.  This area was defined as all points within a twenty-five 
mile radius of Lexington, Kentucky.  This distance was chosen based on proximity to 
population centers, healthcare facilities, and patient willingness-to-commute for 
healthcare services.  A comparator subpopulation not likely to have been effected by the 
intervention was matched based on similar demographics and regional attributes.  This 
area was defined as all in-state points within a twenty-five mile radius of Newport, 
Kentucky.  A map of the Commonwealth of Kentucky divided by zip code can be found 
in Appendix A.  Zip codes used to assign patients to subpopulations are listed in 
Appendix B.   
Each subpopulation was isolated using zip code information available in the 
Kentucky Medicaid claims database.  Additional information of interest available within 
this dataset includes ICD-9 diagnostic codes, patient demographics, prescription records, 
and procedure billing codes.  The database is constructed of multiple tables that may be 
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linked based on common fields, allowing the de-identification of aggregate data.  Patient 
claims data was available for the duration of the sampling time frame.    
Measures 
 In order to measure the effect of the academic detailing intervention on the 
population of interest, frequency of hemoglobin A1c assessment was determined.  The 
frequency of Hemoglobin A1c measurement serves as a surrogate marker of improved 
diabetes care.   More frequent measurement signifies greater adherence with national 
standards of care, and therefore a predicted improvement in patient outcomes.  
Furthermore, an increased frequency of hemoglobin A1c assessment may be related to 
the academic detailing sessions experienced by the primary care providers in the 
intervention area. 
Design 
 The analysis represents a quasi-experimental retrospective analysis of claims data 
comparing two similar regions.  The Fayette county region population was defined as all 
Medicaid patients residing in zip codes within the county boundaries and those zip codes 
within twenty-five miles of Lexington.  The comparator population was defined as all 
Medicaid patients residing in zip codes within the Kenton county boundaries and those 
zip codes within twenty-five miles of Newport.   
Once diabetic subpopulations were isolated the frequency of A1c measurement in 
each region was captured through billing codes in the Medicaid database.  This frequency 
was assessed for two distinct time periods.  The twelve-month period immediately 
preceding the initiation of the DATIS program in Fayette County constituted the pre 
intervention period.  This period ran from March 1, 2002 through February 28, 2003.   
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The following twelve-month period, running from March 1, 2003 through February 28, 
2004 represented the intervention period.  The majority of the academic detailing 
sessions covering Type II diabetes took place during this time frame.  Finally, the next 
twelve-month period, running from March 1, 2004 through February 28,2005 represented 
the post-intervention period.  
 
Results 
Lexington/Fayette County Area   All areas located within a 25-mile radius of 
Lexington, Kentucky as determined by postcodes 
listed in Appendix B  
 
Newport/Campbell County Area  All in-state areas located within a 25-mile radius of 
Newport, Kentucky as determined by postcodes 
listed in appendix B 
 
Rest of State     All in-state areas not included in either region above 
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Sample Data 
 
• Sample Data: Statewide 
 
 Number of 
Diabetics 
 
Male/Female 
# A1c 
Assessments 
A1c Assessment 
per Diabetic 
Pre 
Intervention 
 
43,339 
 
0.444 
 
13,179 
 
31.65% 
Post 
Intervention 
 
47,847 
 
0.463 
 
16,471 
 
34.42% 
 
 
• Sample Data: Lexington/Fayette County Area 
 
 Number of 
Diabetics 
 
Male/Female 
# A1c 
Assessments 
A1c Assessment 
per Diabetic 
Pre 
Intervention 
 
2,960 
 
0.361 
 
925 
 
31.25% 
Post 
Intervention 
 
2,998 
 
0.379 
 
923 
 
30.79% 
 
• Sample Data: Newport/Campbell County Area 
 
 Number of 
Diabetics 
 
Male/Female 
# A1c 
Assessments 
A1c Assessment 
per Diabetic 
Pre 
Intervention 
 
1,668 
 
0.333 
 
502 
 
30.09% 
Post 
Intervention 
 
1,824 
 
0.346 
 
602 
 
33.00% 
 
• Sample Data: Remainder of State 
 
 Number of 
Diabetics 
 
Male/Female 
# A1c 
Assessments 
A1c Assessment 
per Diabetic 
Pre 
Intervention 
 
38,711 
 
0.456 
 
12,292 
 
31.75% 
Post 
Intervention 
 
43,025 
 
0.474 
 
14,946 
 
34.74% 
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Chi Square Test of Difference in Proportions 
 
? Pre-intervention Analysis: All groups 
 
 
Lexington/FC 
 
Newport/CC 
 
Rest of State 
 
 
925 
 
502 
 
12,292 
 
13,179 
 
2,035 
 
1,166 
 
26,419 
 
29,620 
 
2,960 
 
1,668 
 
38,711 
 
 
Chi Square:    2.271 
Degrees of Freedom:   2 
P value:    0.3212 
Conclusion:  No significant difference in the frequency of A1c assessment exists between 
groups prior to the intervention 
 
 
? Pre-Intervention Analysis: Control Group 
  
 
Newport/CC 
 
Rest of State 
 
 
502 
 
12,292 
 
12,794 
 
1,166 
 
26,419 
 
27,585 
 
1,668 
 
38,711 
 
 
 
Chi Square:    2.029 
Degrees of Freedom:   1 
P value:    0.1543 
Conclusion:  No significant difference in the frequency of A1c assessment exists between 
the two groups prior to the intervention. 
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? Pre-Intervention Analysis: Intervention Group 
 
 
Lexington/FC 
 
Rest of State 
 
 
925 
 
12,292 
 
13,217 
 
2,035 
 
26,419 
 
28,454 
 
2,960 
 
38,711 
 
 
 
Chi Square:    0.322 
Degrees of Freedom:   1 
P value:    0.5704 
Conclusion:  No significant difference in the frequency of A1c assessment exists between 
groups prior to the intervention. 
 
? Pre-Intervention Analysis: Intervention vs. Control Group 
 
 
Lexington/FC 
 
Newport/CC 
 
 
925 
 
502 
 
1,427 
 
2,035 
 
1,166 
 
3,201 
 
2,960 
 
1,668 
 
 
 
Chi Square:    0.6648 
Degrees of Freedom:   1 
P value:    0.4144 
Conclusion:  No significant difference in A1c assessment frequency exists between the 
control and intervention groups prior to the intervention. 
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? Post-intervention Analysis  
 
 
Lexington/FC 
 
Newport/CC 
 
Rest of State 
 
 
923 
 
602 
 
14,946 
 
16,471 
 
2,075 
 
1,222 
 
28,079 
 
31,376 
 
2,960 
 
1,668 
 
38,711 
 
 
Chi Square:    21.073 
Degrees of Freedom:   2 
P value:    0.00002655 
Conclusion:  A significant difference in A1c assessment frequency exists between groups 
following the intervention, further testing is warranted to determine where this difference 
lies. 
 
? Post-Intervention Analysis: Control Group 
 
Newport/CC 
 
Rest of State 
 
 
602 
 
14,946 
 
15,548 
 
1,222 
 
28,079 
 
29,301 
 
1,824 
 
43,025 
 
 
 
Chi Square:    2.322 
Degrees of Freedom:   1 
P value:    0.1275 
Conclusion:  No significant difference in A1c assessment frequency exists between the 
groups following the intervention.  
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? Post-Intervention Analysis: Intervention Group 
 
Lexington/FC 
 
Rest of State 
 
 
923 
 
14,946 
 
15,869 
 
2,075 
 
28,079 
 
30,154 
 
2,998 
 
43,025 
 
 
 
Chi Square:    19.364 
Degrees of Freedom:   1 
P value:    0.000012 
Conclusion:  A significant difference in A1c assessment frequency exists between the 
groups following the intervention.  The Lexington/Fayette County area reported 
significantly fewer hemoglobin A1c screenings per diabetic than the rest of the state 
(excluding the Newport region) following the intervention period. 
 
? Post-Intervention Analysis: Intervention vs. Control Group 
 
 
Lexington/FC 
 
Newport/CC 
 
 
923 
 
602 
 
1,525 
 
2,0375 
 
1,222 
 
3,297 
 
2,998 
 
1,824 
 
 
 
Chi Square:    2.5778 
Degrees of Freedom:   1 
P value:    0.10835 
Conclusion:  No significant difference in A1c assessment frequency exists between the 
control and intervention groups following the intervention. 
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? Within group comparison pre and post intervention 
 
? Control Group 
 
 
Newport/CC  
Pre Intervention 
 
Newport/CC 
Post Intervention 
 
 
502 
 
602 
 
1,104 
 
1,166 
 
1,222 
 
2,388 
 
1,668 
 
1,824 
 
 
 
Chi Square:    3.4071 
Degrees of Freedom:   1 
P value:    0.06484 
Conclusion:  No significant difference exists between the frequency of A1c assessment 
reported in the Control area prior to and following the intervention. 
 
 
? Intervention Group 
 
 
Lexington/FC  
Pre Intervention 
 
Lexington/FC 
Post Intervention 
 
 
925 
 
923 
 
1,848 
 
2,035 
 
2,075 
 
4,110 
 
2,960 
 
2,998 
 
 
 
Chi Square:    0.1475 
Degrees of Freedom:   1 
P value:    0.6999 
Conclusion:  No significant difference exists between the frequency of A1c assessment 
reported in the Intervention area prior to and following the intervention. 
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? Rest of State 
 
 
Rest of State  
Pre Intervention 
 
Rest of State 
Post Intervention 
 
 
12,292 
 
14,946 
 
27,238 
 
26,419 
 
28,079 
 
54,498 
 
38,711 
 
43,025 
 
 
 
Chi Square:    81.698 
Degrees of Freedom:   1 
P value:    <<<<0.05 
Conclusion:  A significant difference exists between the frequency of A1c assessment 
reported in the rest of the state prior to and following the intervention. 
 
Discussion & Policy Implications 
Based on the results presented above, this analysis fails to reject the null 
hypothesis.  No statistically significant difference in the frequency of hemoglobin A1c 
assessment was detected between the intervention and control groups prior to or 
following the intervention.  The frequency of hemoglobin A1c assessment remained 
statistically unchanged in the two regions despite an increase in the number of Medicaid 
covered diabetics over the period of analysis. 
 Prior to the intervention, no significant difference in the frequency of hemoglobin 
A1c assessment was detected among the groups.  Following the intervention, a significant 
difference among groups was detected.  Further analysis revealed that while the Fayette 
County and Campbell County regions had not significantly changed relative to baseline, 
the remainder of the state had.  Comparing the areas of the state outside of the two 
subgroups of interest demonstrated a substantial increase in the rate of hemoglobin A1c 
assessment, approximately 3% relative to baseline.  Furthermore, it was determined that 
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the Fayette County region was now significantly lower in assessment frequency than the 
remainder of the State, excluding the Campbell County area.  In effect, the areas that 
received no intervention demonstrated a greater improvement in hemoglobin A1c 
assessment relative to baseline. 
 Evaluating effectiveness of change and quality improvement strategies is often 
challenging. [16].   Any assessed impact of a given strategy must be considered relative 
to other confounding variables.  Without strictly identified populations, it is difficult to 
attribute change to the specific intervention in question.  In the healthcare setting, clinical 
significance must be weighed against cost-effectiveness.  Furthermore, the value of 
preventative care must be examined relative to the potential costs anticipated in the 
absence of such care. Such nebulous standards of valuation lead to difficult paths of 
analysis and make interpretation a challenging task. 
 Accordingly, the policy implications of this research are difficult to interpret.  In 
order to justify expenditure of public funds, a program must demonstrate value-added 
benefit.  Demonstrating the cost effectiveness of behavior change is often more important 
than demonstrating the change itself [17,18].  However, the limitations inherent to the 
required methods of data collection may obscure the true impact of the detailing 
intervention.   
An optimal approach to evaluation would involve collecting patient specific data 
reflective of improved health outcomes and decreased healthcare costs.  These patients 
would be selected based on validated diagnosis and consultation with a provider that had 
received the intervention. Furthermore, both the provider and patient behavior should be 
tracked.  This scrutiny would elucidate the impact of the intervention on both the 
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providers’ behavior patterns and the patient’s response to any change in provider 
behavior.  Such a sample could then be compared against the behavior and outcomes of 
patients who had not received the benefit of such an intervention.  Selecting such a 
sample would also assure that 100% of the providers and patients in the experimental 
group had received the detailing intervention. 
Given the nature of the study variable, additional time may be necessary to realize 
the full effect of the detailing intervention.  Routine assessment of hemoglobin A1c is 
indicated no more than 4 times per year in newly diagnosed patients, and as infrequently 
as twice yearly in stable patients.  The study period examines one year of data, which 
may not allow sufficient time to capture any change in assessment frequency.  This time 
effect may be particularly important due to the strong influence of reinforcement in 
academic detailing sessions.  As the relationship between the provider and detailer grows, 
stronger adherence to key messages of detailing sessions can be expected. 
Any public health initiative should be based on sound policy and analysis.  
Diabetes represents a significant concern for both public health and public finance policy 
makers in the Commonwealth.  Developing cost effective methods to decrease the health 
and financial burden diabetes place on the Commonwealth is imperative.  Such programs 
should be evaluated thoroughly using specific data and appropriate timeframes of 
analysis.   
The DATIS program is based on a sound model of behavior change that has been 
proven effective in the past [8,9].  The program merits a complete quantitative analysis of 
cost-effectiveness combined with qualitative analysis of provider perceptions.  
Quantitative analysis of impact would elucidate the effect the intervention has had on 
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specific patients and healthcare expenditure.  Qualitative analysis would assess the 
perceptions of those providers who have received the intervention.  Combining the results 
of these two approaches would create a sound foundation of analysis on which to base 
policy decisions.  Finally, establishing a standard method of analyzing the impact of such 
a program would allow repeat audit in the future.  Such audit could assess the continuing 
effects of the intervention, directed towards diabetes or other chronic conditions.  Policy 
decisions regarding the continuation of the program could be then are framed based on 
the results of repeat audit relative to baseline.      
Limitations  
 Numerous limitations must be considered when interpreting the gathered data.  A 
primary limitation of this analysis is the use of aggregate data.  Due to confidentiality 
stipulations, it was not possible to isolate providers or patients of providers who directly 
experienced the intervention.  In addition, the parameters of the database selected and the 
number of patients represented by this database account for a large portion of the study 
limitations.  These limitations can be subcategorized by influence on the sample, 
intervention, and analysis. 
Sample Limitations 
 The sample is comprised of Medicaid patients identified as diabetics based on 
ICD-9 diagnosis codes.  Using such parameters to identify patients does not eliminate the 
possibility of including patients who are not indeed diabetics, or excluding patients who 
are diabetics.  Such errors in sampling could serve to either dilute or amplify the 
measured effect of the intervention. Furthermore, this sample can only be interpreted as 
representative of the Medicaid population.  Individuals with private insurance coverage 
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may differ from the Medicaid population in access to healthcare, level of care provided 
per healthcare encounter, and routine follow-up with a healthcare provider.  Finally, the 
intervention was applied on a provider basis, not population basis.  Each provider who 
participated in the intervention serves patients with a variety of different insurance plans.  
Measuring the effects of this intervention using patients identified through only one 
insurance dataset excludes the effect the intervention may have had on patients outside of 
this plan.      
Intervention Limitations 
 The intervention itself was applied on a provider level, while the effect was 
measured on a patient level.  Hemoglobin A1c assessments are seldom conducted by the 
prescribing physician. Instead, the patient must report to an outpatient laboratory to have 
the test performed.  The Medicaid dataset allows the isolation of a billing code for a 
specific procedure, but not the prescription of that procedure.   Therefore, it is not the 
recipients of the academic detailing sessions who are being assessed.  The intervention 
may influence how often an individual physician requests hemoglobin A1c measures, but 
it is the patient who determines how often such assessments are actually completed.  This 
disconnect between intervention and assessment of effect may serve to dilute the impact 
of the intervention.  
 Furthermore, the intervention was not applied to every provider within the Fayette 
County region.  As previously mentioned, confidentiality agreements prevented the 
identification of providers who had participated in the detailing sessions.  As a result, 
aggregate data for all providers within the area of intervention was used.  This approach 
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necessarily includes many providers that did not receive the intervention.  This inclusion 
of non-detailed providers may also serve to dilute the impact of the intervention. 
Analytic Limitations 
 A comparator region was selected based on available demographic information.  
Within the limitations of the database used this region may represent the closest 
comparison for the area of intervention however it is likely that unmeasured regional 
variations could skew the results.  Access to healthcare, utilization of healthcare, and 
additional regional initiatives targeting diabetes could vary between the two areas.  It 
should also be noted that proximity to the Cincinnati major metropolitan area could have 
influenced the results of this comparison.  Patients could choose out of state providers, 
thus decreasing the potential impact of a state level intervention.  Alternatively, 
healthcare standards or initiatives in the Cincinnati area could increase the frequency of 
hemoglobin A1c assessment in residents of Northern Kentucky.      
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Conclusions 
 Based on the results of this analysis, the following recommendations are offered: 
 
R1 Further analysis of the DATIS program is necessary to justify state 
funding.  Such analysis should seek to identify patients and providers 
who have individually experienced the intervention if possible.  
Furthermore, additional surrogate or actual markers of improved 
patient care should be identified. 
 
R2 Subsequent analysis of the DATIS program should incorporate 
qualitative analysis gleaned from provider feedback.  Assessing this 
information may elucidate the perceived value of the DATIS program 
among providers receiving the intervention.  This information may 
supplement the quantitative data available from claims database such 
as the Medicaid information used in this study  
 
R3 The increasing prevalence of Type II diabetes represents a significant 
public health and public finance concern to the Commonwealth of 
Kentucky.  Further exploration and analysis of methods to improve 
outcomes and decrease costs associated with diabetes care are 
warranted. 
 
 
 
Appendix One 
 Kentucky by the counties 
 See attached map 
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Appendix Two 
 Zip Codes in Each Study Arm 
 
Lexington – Fayette County Region 
 
405** 
40347  40324  40383  40356  40339  40361  40391  4047  40390  40372  
40310  40370  40379  40601 
  
 
Newport – Campbell County Region 
 
41071   41072   41076   41099   41048   41080   41005   41091   41095 
41011   41012   41013   41014   41015   41016   41017   41018   41019 
41042   41022   41094   41092   41051   41059   41001   41007   41063 
41006   41033   41030   41035   41095   41035   41052 
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Statistics 
 
Statistical analysis and data management was completed using Microsoft Excel 2000, 
Microsoft Access 2000 and PH Stat statistics software 
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